Medicine News and Research

RSS

Despite high mortality rates, cancer screenings are low in Sub-Saharan Africa

According to the World Health Organization, cervical cancer is the fourth most common form of cancer affecting women worldwide, and those in developing countries face a higher risk of dying from it.

19 May 2021

People with venom allergies are more likely to have bone marrow disorder

Researchers at Michigan Medicine found that people with venom allergies are much more likely to suffer mastocytosis, a bone marrow disorder that causes higher risk of fatal reactions.

19 May 2021

New therapeutic strategy can prevent dental decay in children

The combination of a carb-heavy diet and poor oral hygiene can leave children with early childhood caries (ECC), a severe form of dental decay that can have a lasting impact on their oral and overall health.

19 May 2021

Antibody response following SARS-CoV-2 mRNA vaccine is greater than natural infection

Researchers in the United States have provided the first evidence that messenger RNA (mRNA)-based vaccines against severe acute respiratory coronavirus 2 (SARS-CoV-2) induce a broader array of antibody subtypes against the viral spike protein than natural infection does.

19 May 2021

NYITCOM researcher receives NIH grant to explore effect of stress on clinical depression

A researcher at New York Institute of Technology College of Osteopathic Medicine (NYITCOM) has secured a grant from the National Institutes of Health (NIH) to study how certain brain cells respond to chronic stress.

19 May 2021

Despite sufficient information on COVID-19, Central PA residents worry about mixed messages

Residents of central Pennsylvania had the information they needed to slow the spread of COVID-19 early on in the pandemic, but were overwhelmed with worries about mixed messages and distrust of some sources, according to Penn State College of Medicine researchers.

19 May 2021

AMP and APC urge congress to pass the VITAL Act

The Association for Molecular Pathology (AMP) and the Association of Pathology Chairs (APC) commend U.S. Senator Rand Paul (R-KY) for introducing legislation that would allow molecular pathology professionals to continue advancing and offering high-quality laboratory developed testing procedures (LDPs) for patient care.

19 May 2021

Despite socioeconomic status, racial and ethnic populations endure worse COVID-19 outcomes

A research team, led by the University of Minnesota Medical School, found that regardless of socioeconomic status, Twin Cities residents of underrepresented racial and ethnic backgrounds endure worse COVID-19 outcomes compared to people who are white.

18 May 2021

Western diet impairs the gut immune system, could increase risk of inflammatory bowel disease

Eating a Western diet impairs the immune system in the gut in ways that could increase risk of infection and inflammatory bowel disease, according to a study from researchers at Washington University School of Medicine in St. Louis and Cleveland Clinic.

18 May 2021

Users who pinned healthy recipes on social media are more likely to make unhealthy ones

18 May 2021

Scientists develop experimental direct-acting antiviral therapy to treat COVID-19

An international team of scientists from the Menzies Health Institute Queensland (MHIQ) at Griffith University and from City of Hope, a research and treatment center for cancer, diabetes and other life-threatening diseases in the U.S., have developed an experimental direct-acting antiviral therapy to treat COVID-19.

18 May 2021

Medications commonly prescribed for schizophrenia linked to cognitive impairment

Writing in the May 14, 2021 issue of The American Journal of Psychiatry, a multi-institution team of scientists led by researchers at University of California San Diego School of Medicine report that medications commonly prescribed to reduce the severity of physical and mental health symptoms associated with schizophrenia may have a cumulative effect of worsening cognitive function in patients.

18 May 2021

Study provides new basis to compare the effectiveness of different tuberculosis treatments

A new study published in Nature Communications provides an important new basis for comparing the effectiveness of different tuberculosis treatments.

18 May 2021

New coronavirus test can get fast, accurate results from saliva samples

A new coronavirus test can get accurate results from a saliva sample in less than 30 minutes, researchers report in the journal Nature Communications.

18 May 2021

COVID-19 pandemic causes disproportionate rise in cardiovascular deaths among racial, ethnic minorities

In the early months of the COVID-19 pandemic, the United States experienced higher rates of heart disease and cerebrovascular disease deaths, relative to the corresponding months the previous year.

18 May 2021

Doctors now must provide patients their health data, online and on demand

Last summer, Anna Ramsey suffered a flare-up of juvenile dermatomyositis, a rare autoimmune condition, posing a terrifying prospect for the Los Angeles resident: She might have to undergo chemotherapy, further compromising her immune system during a pandemic.

18 May 2021

Aiding her dying husband, a geriatrician learns the emotional and physical toll of caregiving

The loss of a husband. The death of a sister. Taking in an elderly mother with dementia.

18 May 2021

Owlstone Medical Launches Breath Testing for Digestive Health in Collaboration with Functional Gut Diagnostics and Functional Gut Clinic

Owlstone Medical today announced agreements with Functional Gut Clinic ("FGC") and Functional Gut Diagnostics (“FGD”).

From Owlstone Medical Ltd 18 May 2021

ErbB inhibitor lapatinib exhibits potent anti-SARS-CoV-2 activity

A team of scientists from the USA and Belgium has recently revealed that the ErbB family of receptor tyrosine kinases play a vital role in regulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lifecycle in host cells and that inhibition of these receptors can protect against SARS-CoV-2-induced acute and chronic lung injuries and inflammation.

18 May 2021

Moderna's COVID-19 vaccine elicits six-month antibody responses to variants

Researchers in the United States have demonstrated the long-term durability of the antibody responses elicited by Moderna’s mRNA-1273 vaccine against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

18 May 2021

Medicine News and Research

Despite high mortality rates, cancer screenings are low in Sub-Saharan Africa

People with venom allergies are more likely to have bone marrow disorder

New therapeutic strategy can prevent dental decay in children

Antibody response following SARS-CoV-2 mRNA vaccine is greater than natural infection

NYITCOM researcher receives NIH grant to explore effect of stress on clinical depression

Despite sufficient information on COVID-19, Central PA residents worry about mixed messages

AMP and APC urge congress to pass the VITAL Act

Despite socioeconomic status, racial and ethnic populations endure worse COVID-19 outcomes

Western diet impairs the gut immune system, could increase risk of inflammatory bowel disease

Users who pinned healthy recipes on social media are more likely to make unhealthy ones

Scientists develop experimental direct-acting antiviral therapy to treat COVID-19

Medications commonly prescribed for schizophrenia linked to cognitive impairment

Study provides new basis to compare the effectiveness of different tuberculosis treatments

New coronavirus test can get fast, accurate results from saliva samples

COVID-19 pandemic causes disproportionate rise in cardiovascular deaths among racial, ethnic minorities

Doctors now must provide patients their health data, online and on demand

Aiding her dying husband, a geriatrician learns the emotional and physical toll of caregiving

Owlstone Medical Launches Breath Testing for Digestive Health in Collaboration with Functional Gut Diagnostics and Functional Gut Clinic

ErbB inhibitor lapatinib exhibits potent anti-SARS-CoV-2 activity

Moderna's COVID-19 vaccine elicits six-month antibody responses to variants

Everything there is to know about biosimilars eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News